news

Year:

2024-03-07

Risen's innovative KRAS drug research result has been selected for presentation at the AACR Annual Meeting 2024 in San Diego, California!

2023-12-20

Risen found status in the "2023 Hurun Global Cheetah Enterprise List"

2023-06-13

Congratulations! Risen successfully acquired Biosafety Laboratory level 2 (BSL-2) qualification.

2023-04-10

Congratulations! Risen laned in “KPMG China Biotech Future Sector 50 Ranking”

2023-03-13

Congratulations! Risen was entitled as a "special and innovative" small to medium-sized enterprise in Shanghai

2023-02-03

First in China: ANGPTL3 siRNA drug developed Risen and TopAlliance jointly approved for clinical trial.

Shanghai Zhangjiang R&D Center.

Suzhou Industrial Park R&D Center.